共 100 条
[1]
Li J(2021)COVID-19 illness and autoimmune diseases: recent insights Inflamm Res 70 1-20
[2]
Liu HH(2020)Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev 19 102524-9
[3]
Yin XD(2021)COVID-19 outcomes in patients with systemic autoimmune rheumatic Diseases compared to the General Population: a US Multicenter, comparative cohort study Arthritis Rheumatol 73 914-4
[4]
Li CC(2021)Social Distancing, Health Care Disruptions, Telemedicine Use, and treatment interruption during the COVID-19 pandemic in patients with or without Autoimmune Rheumatic Disease ACR Open Rheumatol 3 381-16
[5]
Wang J(2021)Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic patients Jt bone spine 88 105085-58
[6]
Caso F(2020)What does the COVID-19 Pandemic Mean for Rheumatology Patients? Curr Treatm Opt Rheumatol 6 71-9
[7]
Costa L(2021)Healthcare Resource Use in patients with Immune-Mediated conditions treated with targeted Immunomodulators during COVID-19 pandemic: a retrospective claims analysis Adv Ther 38 5302-40
[8]
Ruscitti P(2020)COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia Acta Med Indones 52 299-81
[9]
D’Silva KM(2022)APLAR recommendations on the practice of telemedicine in rheumatology Int J Rheum Dis 25 247-7
[10]
Jorge A(2020)Indonesian Medical Council regulation number 74 of 2020 concerning Clinical Authority and Medical Practice through Telemedicine during the Corona Virus Disease 2019 (COVID-19) pandemic in Indonesia Published online April 30 1-63